J9044 – Injection, bortezomib, not otherwise specified, 0.1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9044
- Long description
- Injection, bortezomib, not otherwise specified, 0.1 mg
- Short description
- Inj, bortezomib, nos, 0.1 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Added
- January 1, 2019
- Last change
- January 1, 2023 – No change
- Termination date
- December 31, 2022
Frequently asked questions
What is HCPCS code J9044?
J9044 is a HCPCS Level II code for injection, bortezomib, not otherwise specified, 0.1 mg. It was discontinued on December 31, 2022.
Does Medicare cover J9044?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9036 – Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
- J9037 – Injection, belantamab mafodotin-blmf, 0.5 mg
- J9038 – Injection, axatilimab-csfr, 0.1 mg
- J9039 – Injection, blinatumomab, 1 microgram
- J9040 – Injection, bleomycin sulfate, 15 units
- J9041 – Injection, bortezomib, 0.1 mg
- J9042 – Injection, brentuximab vedotin, 1 mg
- J9043 – Injection, cabazitaxel, 1 mg
- J9045 – Injection, carboplatin, 50 mg
- J9046 – Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg
- J9047 – Injection, carfilzomib, 1 mg
- J9048 – Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg
- J9049 – Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg
- J9050 – Injection, carmustine, 100 mg
- J9051 – Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg
- J9052 – Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.